• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Japan firm seeks approval for stem cell treatment for Parkinson’s

August 5, 2025
in Medical Research
Reading Time: 2 mins read
A A
0
Parkinson
2
SHARES
4
VIEWS
Share on FacebookShare on Twitter


Parkinson
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson’s disease. Credit: Wikipedia

Japanese drugmaker Sumitomo Pharma said Tuesday it is seeking approval for a Parkinson’s disease treatment that transplants stem cells into a patient’s brain, following a successful clinical trial.

The company applied to Japanese regulators for manufacturing and marketing authorization aimed at the treatment of patients with advanced Parkinson’s disease, it said in a statement.

A trial led by Kyoto University researchers indicated that the company’s treatment using induced pluripotent stem (iPS) cells—which have the potential to develop into any cell in the body—was safe and successful in improving symptoms.

The study involved seven Parkinson’s patients aged between 50 and 69, with each receiving a total of either five million or 10 million cells implanted on both sides of the brain.

The iPS cells from healthy donors were developed into the precursors of dopamine-producing brain cells, which are no longer present in people with Parkinson’s disease.

The patients were monitored for two years and no major adverse effects were found, the study said. Four patients showed improvements in symptoms, it said.

The trial results were published in Nature in April.

Sumitomo Pharma is also carrying out a clinical trial in the United States.

Parkinson’s disease is a chronic, degenerative neurological disorder that affects the body’s motor system, often causing shaking and other difficulties in movement.

Worldwide, about 10 million people have the illness, according to the Parkinson’s Disease Foundation.

Currently available therapies “improve symptoms without slowing or halting the disease progression,” the foundation says.

iPS cells are created by stimulating mature, already specialized, cells back into a juvenile state—basically cloning without the need for an embryo.

The cells can be transformed into a range of different types of cells, and their use is a key sector of medical research.

© 2025 AFP

Citation:
Japan firm seeks approval for stem cell treatment for Parkinson’s (2025, August 5)
retrieved 5 August 2025
from https://medicalxpress.com/news/2025-08-japan-firm-stem-cell-treatment.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Parkinson
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson’s disease. Credit: Wikipedia

Japanese drugmaker Sumitomo Pharma said Tuesday it is seeking approval for a Parkinson’s disease treatment that transplants stem cells into a patient’s brain, following a successful clinical trial.

The company applied to Japanese regulators for manufacturing and marketing authorization aimed at the treatment of patients with advanced Parkinson’s disease, it said in a statement.

A trial led by Kyoto University researchers indicated that the company’s treatment using induced pluripotent stem (iPS) cells—which have the potential to develop into any cell in the body—was safe and successful in improving symptoms.

The study involved seven Parkinson’s patients aged between 50 and 69, with each receiving a total of either five million or 10 million cells implanted on both sides of the brain.

The iPS cells from healthy donors were developed into the precursors of dopamine-producing brain cells, which are no longer present in people with Parkinson’s disease.

The patients were monitored for two years and no major adverse effects were found, the study said. Four patients showed improvements in symptoms, it said.

The trial results were published in Nature in April.

Sumitomo Pharma is also carrying out a clinical trial in the United States.

Parkinson’s disease is a chronic, degenerative neurological disorder that affects the body’s motor system, often causing shaking and other difficulties in movement.

Worldwide, about 10 million people have the illness, according to the Parkinson’s Disease Foundation.

Currently available therapies “improve symptoms without slowing or halting the disease progression,” the foundation says.

iPS cells are created by stimulating mature, already specialized, cells back into a juvenile state—basically cloning without the need for an embryo.

The cells can be transformed into a range of different types of cells, and their use is a key sector of medical research.

© 2025 AFP

Citation:
Japan firm seeks approval for stem cell treatment for Parkinson’s (2025, August 5)
retrieved 5 August 2025
from https://medicalxpress.com/news/2025-08-japan-firm-stem-cell-treatment.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Trump removes Biden appointee commissioner after disappointing jobs data

Next Post

Can EV ambassadors help Chicago drivers go electric?

Related Posts

'Sweet' discovery reveals how glucose fuels cancer-fighting immune cells

Glucose helps T cells build cancer-fighting structures, not just provide energy

August 5, 2025
8
Florida officials warn about raw milk after 21 people are sickened

Florida officials warn about raw milk after 21 people are sickened

August 5, 2025
8
Next Post

Can EV ambassadors help Chicago drivers go electric?

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Police ID man who died after Corso Italia fight

December 23, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
Is this Tom Izzo's last chance at another title at Michigan State?

ULM’s Vincent named interim AD after Hartwell’s resignation todayheadline

August 5, 2025
The ousted founder of millennial athleisure darling Outdoor Voices has resurfaced: 'We're back, baby'

The ousted founder of millennial athleisure darling Outdoor Voices has resurfaced: ‘We’re back, baby’ todayheadline

August 5, 2025
Amgen profit rises, weight-loss data expected in 4th quarter

Amgen profit rises, weight-loss data expected in 4th quarter todayheadline

August 5, 2025

Cisco Hit With Data Breach Caused By a Voice Phishing Attack todayheadline

August 5, 2025

Recent News

Is this Tom Izzo's last chance at another title at Michigan State?

ULM’s Vincent named interim AD after Hartwell’s resignation todayheadline

August 5, 2025
7
The ousted founder of millennial athleisure darling Outdoor Voices has resurfaced: 'We're back, baby'

The ousted founder of millennial athleisure darling Outdoor Voices has resurfaced: ‘We’re back, baby’ todayheadline

August 5, 2025
6
Amgen profit rises, weight-loss data expected in 4th quarter

Amgen profit rises, weight-loss data expected in 4th quarter todayheadline

August 5, 2025
5

Cisco Hit With Data Breach Caused By a Voice Phishing Attack todayheadline

August 5, 2025
5

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

Is this Tom Izzo's last chance at another title at Michigan State?

ULM’s Vincent named interim AD after Hartwell’s resignation todayheadline

August 5, 2025
The ousted founder of millennial athleisure darling Outdoor Voices has resurfaced: 'We're back, baby'

The ousted founder of millennial athleisure darling Outdoor Voices has resurfaced: ‘We’re back, baby’ todayheadline

August 5, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co